Home › Lymphoma › Pennsylvania › Pittsburgh

Pag-aaral pangklinika para sa Lymphoma sa Pittsburgh, PA

Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Pittsburgh. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

University of Pittsburgh Medical Center (UPMC), Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04234048

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Nagre-recruitPhase 2

UPMC Hillman Cancer Center, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221500

Collection of Tissue Samples for Cancer Research

Nagre-recruitObservasyonal na pag-aaral

University of Pittsburgh Medical Center, Pittsburgh

2 Months · Lahat ng kasarian · Na-update Set 16, 2026 · NCT00900198

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Nagre-recruitPhase 1/2

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Nagre-recruitPhase 3

Research Site, Pittsburgh

Edad 18 hanggang 18 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07509151

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

West Penn Hospital, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Allegheny Health Network, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Allegheny Health Network Cancer Institute, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Nagre-recruitPhase 1/2

Dren Investigational Site 2, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT05475925

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Nagre-recruitPhase 1/2

UPMC Hilman Cancer Center, Pittsburgh

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT03328078

Pag-aaral para sa Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Pittsburgh

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.